Demo Sign up Log In

Bausch Health Companies Inc. Common Stock (BHC)

Cost of Revenue

$3.06B

TTM · Period ending: Jun 30, 2026 · USD

BHC Cost of Revenue

Latest reported$3.06Bperiod endingJun 30, 2026

Latest reported$3.06Bperiod endingJun 30, 2026

BHC TTM Cost of Revenue ($0.00 → $3.06B)

TTM cost of revenue

High-resolution chart · PNG

BHC cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bausch Health Companies Inc. Common Stock Cost of Revenue — Trailing twelve months (TTM) (USD)
Period ending	Cost of Revenue (USD)
Jun 30, 2001	107,564,000
Mar 31, 2001	89,090,000
Dec 31, 2000	68,031,000
Sep 30, 2000	37,845,000
Jun 30, 2000	33,055,000
Mar 31, 2000	30,195,000
Dec 31, 1999	28,200,000
Sep 30, 1999	24,900,000
Jun 30, 1999	23,500,000
Mar 31, 1999	23,100,000
Dec 31, 1998	23,600,000
Sep 30, 1998	34,300,000
Jun 30, 1998	30,700,000
Mar 31, 1998	28,800,000
Dec 31, 1997	28,900,000
Sep 30, 1997	14,300,000
Jun 30, 1997	18,600,000
Mar 31, 1997	21,400,000
Dec 31, 1996	23,200,000
Sep 30, 1996	19,000,000
Jun 30, 1996	12,600,000
Mar 31, 1996	5,900,000
Dec 31, 1995	1,200,000
Sep 30, 1995	1,200,000
Jun 30, 1995	1,200,000
Mar 31, 1995	1,200,000
Dec 31, 1994	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.